Cardiome Pharma (CRME) Signs Major License Agreement With Merck (MRK) for Vernakalant
Tweet Send to a Friend
Merck & Co., Inc. (NYSE: MRK) and Cardiome Pharma Corp. (NASDAQ: CRME) announced a collaboration and license agreement for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
